Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorBruyère Health Research Institute.
About this trial
The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:
1. After 3 months of being discharged from the hospital, does this additional volunteer support at home improve coping skills for stroke survivors? 2. Does the effects of the volunteer support last over 3 to 6 months after being discharged home?
Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.
Participants will:
* Either receive volunteer support over an 8-week time period OR receive no additional volunteer support * Continue with their usual care plan and receive educational resources from the research team during the study * Complete online surveys during study enrollment, at 3 months, and at 6 months after hospital discharge
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Confirmed diagnosis of stroke
Either undergoing or recently completed in-patient rehabilitation within the last 3 weeks
Lived at home pre-stroke
Discharged directly home (to own residence or that of a family member)
Disqualifiers
Discharged to additional hospital inpatient care, nursing home, or other long-term care
Inability to communicate in English
Inability to provide informed consent due to cognitive deficits
Trial design
Design model
Parallel
Treatments tested in this trial
Discharge Assistance and Supports at Home (DASH)
BehavioralOne-on-one weekly visits in the stroke survivor participants' residence by a trained volunteer for approximately 8 weeks (about 2 months). Volunteer support could span three types: i) instrumental activities of daily living assistance (e.g., assistance with meal preparation, light house duties, and transportation), ii) psychosocial support (e.g., befriending visits), and iii) informational supports (signposting to other community services).
Treatment groups
840 Participants
are divided into 2 treatment groupsGroup A: Group A: DASH groupExperimental treatment 1 intervention
Group B: Group B: Usual care groupNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Coping at Time 1 as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported outcome measure evaluating perceived difficulty coping following hospital discharge. Each item is scored on a scale from 0 to 10. Item scores are summed to yield a total score ranging from 0 to 100, with higher scores indicating greater difficulty coping.
Time frame
Measured at 3 months post-hospital dischargeSecondary outcomes
1
Change in coping as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported measure. Each item is scored from 0 to 10, with total scores ranging from 0 to 100. Change in total score will be calculated between time points. Higher scores indicate greater difficulty coping.
Time frame
Measured at 3 months and 6 months post-hospital discharge2
Change in quality of life as assessed by Stroke-Specific Quality of Life (SS-QOL)
Quality of life will be assessed using the Stroke-Specific Quality of Life (SS-QOL) scale, a 49-item patient-reported measure evaluating multiple domains of health-related quality of life in stroke survivors. Each item is scored on a 5-point Likert scale (1 to 5). Domain scores are calculated as the average of items within each domain, and the overall score is calculated as the average of all domain scores or as the sum of all 49 items (ranging 49 to 245). Higher scores indicate better quality of life.
Time frame
Measured at 3 months and 6 months post-hospital discharge3
Change in symptoms of depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item patient-reported measure. Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
Time frame
Measured at 3 months and 6 months post-hospital discharge4
Change in social isolation and loneliness indicators as assessed by UCLA Loneliness Scale (Version 3)
Social isolation and loneliness will be assessed using the UCLA Loneliness Scale (Version 3), a 20-item patient-reported measure evaluating subjective feelings of loneliness and social isolation. Each item is scored on a 4-point scale. Total scores range from 20 to 80, with higher scores indicating greater loneliness.
Time frame
Measured at 3 months and 6 months post-hospital dischargeSponsors and contacts
Click on the lead sponsor to view all of their trials.
Bruyère Health Research Institute.
Lead sponsor
March of Dimes, Canada
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: